MAXACALCITOL: 45 Adverse Event Reports & Safety Profile
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
45
Total FAERS Reports
7 (15.6%)
Deaths Reported
34
Hospitalizations
45
As Primary/Secondary Suspect
1
Life-Threatening
First Report: 201105 · Latest Report: 20250601
What Are the Most Common MAXACALCITOL Side Effects?
#1 Most Reported
Hypercalcaemia
10 reports (22.2%)
#2 Most Reported
Hypocalcaemia
6 reports (13.3%)
#3 Most Reported
Shunt stenosis
4 reports (8.9%)
All MAXACALCITOL Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Hypercalcaemia | 10 | 22.2% | 2 | 8 |
| Hypocalcaemia | 6 | 13.3% | 0 | 6 |
Who Reports MAXACALCITOL Side Effects? Age & Gender Data
Gender: 50.7% female, 49.3% male. Average age: 63.9 years. Most reports from: JP. View detailed demographics →
Is MAXACALCITOL Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2014 | 2 | 1 | 2 |
| 2015 | 1 | 0 | 1 |
| 2016 | 3 | 0 | 2 |
| 2017 | 2 | 0 | 2 |
| 2018 | 8 | 3 | 8 |
| 2019 | 10 | 1 | 7 |
| 2020 | 1 | 0 | 1 |
| 2021 | 2 | 0 | 2 |
| 2022 | 1 | 0 | 0 |
| 2024 | 1 | 0 | 1 |
| 2025 | 2 | 1 | 1 |
What Is MAXACALCITOL Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 19 |
| Hyperparathyroidism secondary | 9 |
| Psoriasis | 8 |
Official FDA Label for MAXACALCITOL
Official prescribing information from the FDA-approved drug label.